More search options
Basket icon
No items
Basket icon

Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Compact case
Case
-
Reference no. 9-920-011
Subject category: Finance, Accounting and Control
Authors: Srikant M Datar
Published by: Harvard Business Publishing
Originally published in: 2000
Version: 25 May 2000
Revision date: 13-Jan-2020
Length: 5 pages
Data source: Published sources
Topics: Accounting; Accounting procedures; Cost accounting; Cost analysis; Fixed costs; Present value; Product management
Share a link: https://casecent.re/p/166692
| No reviews for this item
This product has not been used yet
View our pricing guide or login to see prices.

Abstract

Should Novartis drop 20% of its global pharmaceutical product brands that account for only 3% of its pharmaceutical revenues?
Location:
Switzerland
Industry:
Pharmaceuticals
Size:
USD15 billion revenues; 89,000 employees
Other setting(s):
1999
Teaching note
-
Reference no. 5-113-111
Subject category: Finance, Accounting and Control
Authors: Srikant M Datar
Published by: Harvard Business Publishing
Originally published in: 2013
Version: 4 March 2013
Revision date: 14-Mar-2013
Length: 7 pages
View full details
Supplement
-
Reference no. 9-920-010
Subject category: Finance, Accounting and Control
Authors: Christine L Exley; Katherine B Coffman; Joshua Schwartzstein
Published by: Harvard Business Publishing
Originally published in: 2019
Version: 14 August 2019
Revision date: 14-Jan-2020
Length: 6 pages
Data source: Generalised experience
Topics: Accounting; Activity-based costing; Distribution; Materials management; Performance measurement; Pricing; Supply chain management
View full details

About

Abstract

Should Novartis drop 20% of its global pharmaceutical product brands that account for only 3% of its pharmaceutical revenues?

Settings

Location:
Switzerland
Industry:
Pharmaceuticals
Size:
USD15 billion revenues; 89,000 employees
Other setting(s):
1999

Related

Teaching note
-
Reference no. 5-113-111
Subject category: Finance, Accounting and Control
Authors: Srikant M Datar
Published by: Harvard Business Publishing
Originally published in: 2013
Version: 4 March 2013
Revision date: 14-Mar-2013
Length: 7 pages
View full details
Supplement
-
Reference no. 9-920-010
Subject category: Finance, Accounting and Control
Authors: Christine L Exley; Katherine B Coffman; Joshua Schwartzstein
Published by: Harvard Business Publishing
Originally published in: 2019
Version: 14 August 2019
Revision date: 14-Jan-2020
Length: 6 pages
Data source: Generalised experience
Topics: Accounting; Activity-based costing; Distribution; Materials management; Performance measurement; Pricing; Supply chain management
View full details